National Osteoporosis Foundation. Clinician’s guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation, 2008.
34.
Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637– 1642.
35.
Bischoff-Ferrari H, Willett W, Wong J, et al. Prevention of non-vertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009;169:551–561.
36.
Jackson R, LaCroix A, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669– 683.
37.
World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. Welcome to FRAX. Available at http://www.sheffield.ac.uk/FRAX/. A ccessed September 15, 2011.
38.
Watts N, Ettinger B, LeBoff M. Perspective: FRAX facts. J Bone Min Res 2009;24:975–979.
39.
Cauley J, Zmuda J, Ensrud K, et al. Timing of estrogen replacement therapy for optimal osteoporosis prevention. J Clin Endocrinol Metab 2001;86:5700–5705.
40.
Cauley J, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density. JAMA 2003;290:1729.
41.
Ettinger B, Ensrud K, Wallace R, et al. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obset Gynecol 2004;104:443–451.
42.
Cummings S, Black D, Thompson D, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 1998;280:2077–2082.
43.
Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with post-menopausal osteoporosis. JAMA 1999;282:1344–1352.
44.
Black D, Delmas P, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809–1822.
45.
MORE Investigators. Reduction of vertebral fracture risk in post-menopausal women with osteoporosis treated with raloxifene. JAMA 1999;282:637–645.
46.
Neer R, Arnaud C, Zanchetta J, et al. Effect of parathyroid hormone on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434–1441.
47.